➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

PEGINTRON Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: PEGINTRON

Patents:	33
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for PEGINTRON

Recent Clinical Trials for PEGINTRON

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Third Affiliated Hospital, Sun Yat-Sen University	N/A
Philadelphia Fight	Phase 1
Luis Montaner	Phase 1

See all PEGINTRON clinical trials

Pharmacology for PEGINTRON

Ingredient-type	Interferon Alfa-2b Interferon-alpha

Company Disclosures: US Patents for PEGINTRON

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for PEGINTRON

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE)	2031-04-05	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial		2040-03-24	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	ForSight Vision4, Inc. (South San Francisco, CA)	2029-01-29	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for PEGINTRON

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	101171034	Start Trial
Australia	2014293670	Start Trial
Japan	2010516675	Start Trial
European Patent Office	2646055	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

AstraZeneca

Colorcon

McKinsey

McKesson

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.